91 related articles for article (PubMed ID: 7611995)
1. HIV infection decreases intracellular nicotinamide adenine dinucleotide [NAD].
Murray MF; Nghiem M; Srinivasan A
Biochem Biophys Res Commun; 1995 Jul; 212(1):126-31. PubMed ID: 7611995
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection.
Murray MF; Srinivasan A
Biochem Biophys Res Commun; 1995 May; 210(3):954-9. PubMed ID: 7763268
[TBL] [Abstract][Full Text] [Related]
3. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
4. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
Moriuchi H; Moriuchi M
Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of NAD(H) biosynthetic pathway by exogenous NAD+ in Nil cells severely depleted of NAD(H).
Mandel KG; Lively MK; Lombardi D; Amos H
J Cell Physiol; 1983 Feb; 114(2):235-44. PubMed ID: 6218178
[TBL] [Abstract][Full Text] [Related]
6. Role of potassium in human immunodeficiency virus production and cytopathic effects.
Choi B; Gatti PJ; Haislip AM; Fermin CD; Garry RF
Virology; 1998 Aug; 247(2):189-99. PubMed ID: 9705912
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.
Elia C; Cassol E; Sidenius N; Blasi F; Castagna A; Poli G; Alfano M
J Leukoc Biol; 2007 Nov; 82(5):1212-20. PubMed ID: 17704294
[TBL] [Abstract][Full Text] [Related]
8. Different effects of phorbol ester derivates on human immunodeficiency virus 1 replication in lymphocytic and monocytic human cells.
Kalvatchev Z; Walder R; Garzaro D
Acta Virol; 1997 Oct; 41(5):289-92. PubMed ID: 9607083
[TBL] [Abstract][Full Text] [Related]
9. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
[TBL] [Abstract][Full Text] [Related]
10. Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals.
Vieillard V; Lauret E; Maguer V; Jacomet C; Rozenbaum W; Gazzolo L; De Maeyer E
AIDS; 1995 Nov; 9(11):1221-8. PubMed ID: 8561974
[TBL] [Abstract][Full Text] [Related]
11. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
[TBL] [Abstract][Full Text] [Related]
12. Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.
Heredia A; Davis C; Amoroso A; Dominique JK; Le N; Klingebiel E; Reardon E; Zella D; Redfield RR
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4179-84. PubMed ID: 12644703
[TBL] [Abstract][Full Text] [Related]
13. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes.
Petit C; Buseyne F; Boccaccio C; Abastado JP; Heard JM; Schwartz O
Virology; 2001 Jul; 286(1):225-36. PubMed ID: 11448175
[TBL] [Abstract][Full Text] [Related]
14. A stochastic model for early HIV-1 population dynamics.
Tuckwell HC; Le Corfec E
J Theor Biol; 1998 Dec; 195(4):451-63. PubMed ID: 9837702
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide adenine dinucleotide levels in chick limb mesodermal cells in vitro: effects of 3-acetylpyridine and nicotinamide.
Rosenberg MJ; Caplan AI
J Embryol Exp Morphol; 1975 Jul; 33(4):947-56. PubMed ID: 170357
[TBL] [Abstract][Full Text] [Related]
16. Mono Mac 1: a new in vitro model system to study HIV-1 infection in human cells of the mononuclear phagocyte series.
Genois N; Robichaud GA; Tremblay MJ
J Leukoc Biol; 2000 Dec; 68(6):854-64. PubMed ID: 11129653
[TBL] [Abstract][Full Text] [Related]
17. Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells.
Yang T; Chan NY; Sauve AA
J Med Chem; 2007 Dec; 50(26):6458-61. PubMed ID: 18052316
[TBL] [Abstract][Full Text] [Related]
18. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
[TBL] [Abstract][Full Text] [Related]
19. Circadian tracking of nicotinamide cofactor levels in an immortalized suprachiasmatic nucleus cell line.
Wise DD; Shear JB
Neuroscience; 2004; 128(2):263-8. PubMed ID: 15350639
[TBL] [Abstract][Full Text] [Related]
20. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
